Rothschild Capital Partners’s Cogentix Medical, Inc. CGNT Stock Holding History

Rothschild Capital Partners’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-386,276	Closed	-$479K	–	46
2015 Q3	$479K	Sell	386,276 -49,064	-11%	-$75.2K	0.25%	31
2015 Q2	$705K	Buy	+435,340	New	+$713K	0.3%	29

Other funds holding CGNT

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Rothschild Capital Partners's CGNT Position: Q4 2015 in Review

Rothschild Capital Partners sold out of Cogentix Medical, Inc. (CGNT) in Q4 2015, closing a stake of 386,276 shares — an estimated $479K sold.

Rothschild Capital Partners first reported a position in CGNT in Q2 2015 and held it in 2 quarters. The position peaked at $705K in Q2 2015. 38 funds tracked by Wall St. Rank hold CGNT as of Q4 2015.

Rothschild Capital Partners reported no remaining Cogentix Medical, Inc. position as of Q4 2015 after selling out during the quarter.
Rothschild Capital Partners sold 386,276 Cogentix Medical, Inc. shares in Q4 2015, an estimated $479K.
Rothschild Capital Partners first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 2 quarters.
Rothschild Capital Partners's Cogentix Medical, Inc. position peaked at $705K in Q2 2015.
38 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q4 2015.

Based on Rothschild Capital Partners's 13F filing for Q4 2015, filed 2 Feb 2016.